Kite Pharma vs Signadori Bio
Kite Pharma vs Signadori Bio, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Kite Pharma is on 66/100 and Signadori Bio on 45/100.
Where each one leads
Kite Pharma
- our overall score: 66/100 against 45/100
- domain rating: 62/100 against 6/100
- funding raised: $421M against $12.2M
Signadori Bio
- agent readiness: 40/100 against 35/100
At a glance
| Measure | Kite Pharma | Signadori Bio |
|---|---|---|
| What it is | Biotechnology company developing and commercializing cell therapies for cancer treatment. | Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors. |
| Category | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy | Biotechnology, Pharmaceuticals, Oncology, Immunotherapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2009 | 2025 |
| Headquarters | Santa Monica, United States | Paris, France |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Kite Pharma | Signadori Bio |
|---|---|---|
| Total funding | $421M | $12.2M |
| Latest round | Venture | Seed Extension |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Kite Pharma | Signadori Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 66/100 | 45/100 |
| Traction | 40/100 | 35/100 |
| Team | 80/100 | 70/100 |
| Search visibility | 15/100 | 16/100 |
| Quality | 90/100 | 50/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | D (40/100) |
| Domain ratingLink authority, 0-100 | 62/100 | 6/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Kite Pharma | Signadori Bio |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | Lovable |
| Frameworks | Tailwind CSS, Bootstrap | Not detected |
| Analytics | Google Tag Manager | Not detected |
Kite Pharma vs Signadori Bio: common questions
Which is better, Kite Pharma or Signadori Bio?
On our 0-100 score Kite Pharma rates higher (66/100 against 45/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Kite Pharma and Signadori Bio compare on the numbers?
Kite Pharma leads on our overall score (66/100 against 45/100), domain rating (62/100 against 6/100), funding raised ($421M against $12.2M). Signadori Bio leads on agent readiness (40/100 against 35/100).
Read the full Kite Pharma review and pricing or the Signadori Bio review and pricing. You can also browse other Kite Pharma alternatives we track.